Rikard Grankvist
CEO
MD, PhD
Next generation of heart biopsy
Microcardix is developing a novel heart biopsy technique to enable the precision medicine revolution in cardiovascular medicine. More flexible and less traumatic than conventional devices, designed for modern molecular analysis techniques.
Learn about our technologyOur Technology
Microcardix is an endovascular microcatheter-based device designed for harvesting minimal tissue samples of the heart and organs near major vessels, such as the lungs, liver, and kidneys.
In the heart, the device has a favorable safety profile compared to conventional devices, due to its small size and mechanism of action.
Patent pending.
Team
Staffan Holmin
CMO
MD, Prof.
Mikael Sandell
CTO
MSc Eng.
Arvin Chireh
Head of Molecular Analysis
MD, PhD
Stefan Jonsson
Technical Director
Prof.
Board
Staffan Holmin
Chairman
MD, Prof.
Magnus Settergren
Board Memmber, KOL in Interventional Cardiology
MD, Assoc. Prof.
Magnus Oppenstam
Board Member, Financial Advisor
Financial Sector Executive
Publications
-
Grankvist, R. et al. Myocardial micro-biopsy procedure for molecular characterization with increased precision and reduced trauma. Scientific Reports 10, 1–11 (2020).
Article on Scientific Reports → -
Chireh, A. et al. Micro-biopsy for detection of gene expression changes in ischemic swine myocardium: A pilot study. PLoS One 16, e0250582 (2021).
Article on PLoS One → -
Chireh, A. et al. Safety evaluation of high-risk myocardial micro-biopsy in a swine model. Heart Vessels (2021) doi:10.1007/s00380-021-01995-9.
Article in Heart and Vessels →
About the company
Microcardix was founded in 2020 as a spin out from Karolinska Institutet. It is part of KI Innovations incubator DRIVE.
News
Loading news…